See every side of every news story
Published loading...Updated

Slow Adalimumab Tapering May Cut Risk for Uveitis Relapse

Summary by Medscape
A retrospective cohort analysis shows that pediatric patients with noninfectious uveitis face lower recurrence rates when adalimumab is tapered slowly after remission. Medscape Medical News

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Wednesday, April 16, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.